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Aims: To investigate the feasibility of discrete choice experiments
for valuing EQ-5D-5L states using computer-based data collection,
the consistency of the estimated regression coefficients produced
after modeling the preference data, and to examine the similarity of
the values derived across countries.
Methods: Data were collected in Canada, England, The Nether-
lands, and the United States (US). Interactive software was devel-
oped to standardize the format of the choice tasks across countries,
except for face-to-face interviewing in England. The choice task
required respondents to choose between 2 suboptimal health states.
A Bayesian design was used to generate 200 pairs of states that
were randomly grouped into 20 blocks. Each respondent completed
1 block of 10 pairs. A main-effects probit model was used to esti-
mate regression coefficients and to derive values.
Results: Approximately 400 respondents participated from each
country. The mean time to perform 1 choice task was between 29.2
(US) and 45.2 (England) seconds. All regression coefficients were
statistically significant, except level 2 for Usual Activities in The
Netherlands (P= 0.51). Predictions for the complete set of 3125
EQ-5D-5L health states were similar for the 4 countries. Intraclass
correlation coefficients between the countries were high: from 0.80
(England vs. US) through 0.98 (Canada vs. US).
Conclusions: Derivation of value sets from the general population
using computer-based choice tasks for the EQ-5D-5L is feasible.
Parameter estimates were generally consistent and logical, and
health-state values were similar across the 4 countries.
Key Words: EQ-5D-5L, health states, choice model, values, dis-
crete choice experiment
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One of the goals of the preference-based approach toquantifying health is to express overall health-related
quality of life or health status in a single metric. These
health-state values (also known as utilities, preference
scores, or weights) are often combined with survival (ie,
longevity) data to compute quality-adjusted life years. The
latter summary measure is often used to inform economic
evaluations of health care interventions.
Several techniques are used to elicit values for health
states from individuals, notably the standard gamble, time
trade-off (TTO), rating/visual analog scale, magnitude esti-
mation, and person trade-off.1–3 Discrepancies between their
outcomes, and a lack of consensus on which technique yields
optimal results, continues to stimulate research into ap-
proaches to value health. Discrete choice models to quantify
values of health states represent a growing area of interest.
This approach builds upon an established practice of using
ordinal responses to estimate interval or cardinal mea-
sures.4–8 Discrimination mechanisms are central to this
measurement framework, and belong to the statistical class
of probabilistic choice models. In quantifying health, this
entails making choices between 2 or more health states or
health profiles, depending on the objective.9
Choice models are grounded in modern measurement
theory and are consistent with the random utility model in
economic theory.9 All of these choice models are based on
statistical techniques (eg, logit or probit regression models), and
are used to establish the relative merit of 1 phenomenon with
respect to others. If the phenomena have specific attributes
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(eg, health domains or attributes) with certain levels, extended
choice models permit the estimation of their relative importance
and of overall values for different combinations of attribute
levels.10
As an international collaborative research group in-
terested in health valuation, scientists involved in the Euro-
Qol Group have experimented with health-valuation
techniques, particularly the TTO, in developing value sets
for the EQ-5D-3L.11 Perceived shortcomings of the current
TTO protocol prompted experimentation with variants such
as lead-time TTO.12 Parallel to this developmental work, the
EuroQol Group also investigated a choice-based modeling
approach to the valuation of health. This research was in-
stigated by the development of a 5-level EQ-5D (the EQ-5D-
5L), which expanded the number of levels from 3 to 5, each
of which is labeled.13 The increase in the number of possible
health states from 243 (in the 3L) to 3125 (in the EQ-5D-5L)
prompted an interest in exploring the potential of discrete
choice approaches.
This study had a 3-fold objective: (1) to examine the
feasibility of choice experiments for EQ-5D-5L states using
computer-based data collection; (2) to investigate the con-
sistency of parameter estimates modeled from choice data;
and (3) to explore the similarity of derived health-state val-
ues across different countries.
METHODS
Overview
A study design was developed and implemented in
Canada, England, The Netherlands, and the United States
(US) between September 2010 and August 2011. Values for
EQ-5D-5L health states were elicited by means of TTO (not
presented), visual analog scales (not presented), and a choice
model based on paired comparisons. The responses were
obtained through computer-based interviews (EuroQol Val-
uation Technology). This study was part of a larger pilot
project that tested the performance of the software and IT
infrastructure for running multinational online surveys.
EuroQol-5D-5L
The EQ-5D-5L descriptive system comprises the same
5 dimensions as the EQ-5D with 3 levels, that is, Mobility
(MO), Self-Care (SC), Usual Activities (UA), Pain/Dis-
comfort (PD), Anxiety/Depression (AD). However, in the
EQ-5D-5L the level structure is expanded. In the EQ-5D-5L,
each dimension has 5 levels: no problems, slight problems,
moderate problems, severe problems, and extreme problems/
unable to.13 On the basis of responses to the EQ-5D health-
state classifier, a preference-based scoring function can be
applied that generates a single value for health. The current
study investigates the feasibility of an alternative method for
a scoring function that could be used to derive values.
However, the values reported are not endorsed by the
EuroQol Group or intended to replace existing value sets.
Respondents
In each of the 4 countries, at least 400 persons par-
ticipated in the study. Representative samples were recruited
from the general population (stratified by age, education, and
sex), with a minimum age of 18 years. For the US cohort
participants were recruited from the Chicago area, a pop-
ulous, ethnically diverse urban area. In the England study,
the sample was recruited by approaching through email or
telephone members of a panel of individuals (belonging to
the agency responsible for the fieldwork) who had previously
indicated a willingness to participate in research studies. In
Canada, participants were recruited by random cold phone
call in 2 multiethnic cities: Hamilton and Montreal. English
was used as the survey language in Hamilton, whereas
French was used in Montreal. In The Netherlands re-
spondents were invited by telephone in the Amersfoort area
by an agency. In Canada, The Netherlands, and the US,
participants self-completed the tasks in groups with limited
interviewer assistance (in particular intended for the TTO
task). For these computer-based assessments, about 3 trained
interviewers oversaw groups of approximately 15 re-
spondents in 6–8 sessions per day. In England, identical
software was used; however, a team of 8 home-based in-
terviewers conducted the assessments in face-to-face inter-
views.14 Respondents were paid a small sum for completing
the survey; the exact amount differed by country, ranging
from $20 to $60.
Experimental Design
A Bayesian algorithm was used to generate an efficient
design consisting of 200 paired comparisons (ie, 400 health
states) for which priors were adapted based on an earlier
study.15 Constraints were applied to get a “roughly” level-
balanced design. The number of very mild states for the
EQ-5D-5L generated by the algorithm was low, and some
frequently observed health states were not included. Because
this could lead to less precise estimates of the lower levels of
the domains, 10 pairs were constructed manually and in-
cluded in the design (ie, 1 or 2 domains at level 2, whereas
the other levels are at level 1). The 200 paired comparisons
were subdivided into 20 blocks so that each respondent
would make 10 paired comparisons (Appendix). The order of
the pairs and order within each pair were fully randomized
within a digital setting by using a computer-assisted personal
interview mode of administration: the EuroQol Valuation
Technology.12 We were also able to examine the efficiency
of the design by comparing the predicted health-state values
of all pairs.
Data Collection
All respondents completed the exercises in the same
sequence. First, the respondent was asked to complete the
EQ-5D-5L measure for their own health as a warm-up ex-
ercise. Next, they were given the most simple response task
in the framework of choice modeling: a paired comparison
between 2 different EQ-5D health states (Fig. 1). They per-
formed the 10 forced choice paired comparison tasks. These
paired comparison tasks did not include “dead” or duration
statements (see the Discussion section). No “status quo” or
“opt-out” choices were offered.
Krabbe et al Medical Care  Volume 52, Number 11, November 2014
936 | www.lww-medicalcare.com r 2014 Lippincott Williams & Wilkins
Analysis
The data were analyzed with a multinomial probit re-
gression model (asmprobit, Stata) yielding parameter esti-
mates (regression coefficients) and estimated values for each
health state (applying these coefficients). The parameter
estimates were relevant to evaluate the consistency of the
discrete choice model and the similarity across countries,
whereas the estimated values were only studied to examine
similarity across countries. The main-effects model included
20 dummy variables representing level 2, 3, 4, and 5 for each
of the 5 domains: MO, SC, UA, PD, and AD. It also included
an alternative-specific constant, capturing a tendency to
always choose the first option, which can be considered as
an indicator of feasibility. Expressed in a formula, the
model predicts latent values or utilities v of individuals
choosing health state s; g represents a single vector of un-
known regression coefficients; and zrs indicates a vector of
alternative-specific explanatory variables (eg, dummies) for
individual r.
vrs ¼ gzrs )
vrs ¼ g0ASCþg1MO2þg2MO3þg3MO4þ
g4MO5þg5SC2þ    þg20AD5:
Severe problems in walking about
Moderate problems washing or dressing myself
Unable to do my usual activities
Moderate pain or discomfort
Severely anxious or depressed
Moderate problems in walking about
Slight problems washing or dressing myself
No problems doing my usual activities
Slight pain or discomfort
Extremely anxious or depressed
Which is better, state A or state B?
A B
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FIGURE 1. Example of the paired comparison task for the EQ-5D-5L (top) and the localization (based on logistic regression
resulting in predictions for all 3125 EQ-5D-5L health states) of this pair (EQ-5D-5L states 43534 vs. 32125) in relation to the other
199 pairs (dashed 45-degree line indicates equal values for state A and B; x-axis and y-axis sorted on predicted values for all 3125
states); dark area roughly represents the combinations of the most informative pairs of health states (approximately 70% vs. 30%
preferred by respondents), around diagonal (50% vs. 50%) and in the 2 corners (approximately 90% preference for one of the 2
health states) the noninformative pairs.
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Models were run separately by country to assess the degree
of variability across settings. A model was also run on the
pooled dataset, including all 4 countries with the same 20
dummies.
Logical ordering of parameter estimates in all coun-
tries was used as criterion to assess the consistency of
the models. Differences in parameter estimates between
countries were tested with independent t tests (pooled var-
iance), where P < 0.01 was considered statistically sig-
nificant, to correct for multiple testing. Pearson correlations
were estimated for the predicted 3125 EQ-5D-5L health-state
values to express the similarity between the countries, as
well as intraclass correlations (ICCs; 2-way mixed-effects,
individual ratings, absolute agreement). In addition, graphs
for the pooled data of the 4 countries combined with the data
of the individual countries and their regression functions
were made in SigmaPlot (version 11.0; Systat Software Inc.,
San Jose, CA) to investigate differences in constant and
slope. Respondents were asked to rate the ease and clarity of
the exercise using a 5-point Likert scale (1 = agree, 5 = dis-
agree) and drop-out rates were computed.
RESULTS
Completion
The number of individuals who entered the survey was
547 for Canada, 404 for England, 407 for The Netherlands,
and 417 for the US. A total of 1775 respondents completed
all 17,750 paired comparisons. The number of judgments for
each separate health state in the 4 countries ranged from 15
to 42 (median, 22.5; SD 2.68). In the Dutch study, 1 block of
states (block 11) was not assessed due to a programming
error.
Demographics
Age distribution was similar in the 4 countries, al-
though The Netherlands had a smaller proportion of younger
participants and a larger proportion of middle-aged ones
(Table 1). The mean age in the entire dataset was 40 (SD 16)
years, with a range of 18–100. Regarding sex, the differences
between countries were modest. The samples closely
matched the populations on these key characteristics. Addi-
tional demographic information was collected only for
England and the US. The England sample included a larger
proportion of degree-educated and employed individuals
compared with the general population in England, but the
sample was broadly representative of the general population
in terms of other background characteristics, such as eth-
nicity.16 Among US respondents, 70.8% reported that they
received education beyond high school; 65.8% were non-
Hispanic white (n = 273), 17.6% were African American
(n = 73), and 16.6% were all other ethnicities.
Feasibility
The drop-out (not completing all of the valuation tasks)
was low in all countries (England 4, The Netherlands 14).
For The Netherlands and England, the average duration (s)
per task was 32.5 and 45.2, respectively. For Canada it was
35.85 (SD 39.50; minimum, 0.81; maximum, 494.1), and for
the US it was 29.16 (SD 37.07; minimum, 0.91; maximum
332.88). Mean responses for Canada, England, The Nether-
lands, and US on the 4 feasibility questions were as follows:
“The instructions that were given on the computer made it
clear what I needed to do” 2.34, 2.27, 2.31, 2.31; “It was easy
to understand the questions I was asked” 3.19, 3.60, 3.32,
3.09; “I found it difficult to decide” 3.87, 3.44, 3.60, 3.86;
“I found it easy to tell the difference between the health states I
was asked to think about” 2.63, 2.47, 2.60, 2.53. The alter-
native-specific constant parameter of the regression model
(Table 2) showed a significant tendency among a subgroup of
respondents in each country to choose the first health state.
Parameters of Choice Models
Four regression coefficients with illogical ordering were
observed in the national datasets (The Netherlands: level 3 MO
and PD were considered less severe than level 2; US: level 3
UA and PD was considered less severe than level 2) and one in
the pooled data (levels 2 and 3 PD were reversed). The spread
of parameter estimates within each domain of health con-
sistently followed the same patterns across domains and across
countries: levels 2 and 3 lowered the values slightly and levels
4 and 5 even more so. All 20 parameters were statistically
significant in all countries, with the exception of level 2 for UA
in The Netherlands (P=0.51) (Table 2).
In comparing the relative value weights assigned to
each dimension, SC and UA were generally assigned less
weight than the other 3 domains, although there were dif-
ferences between countries. Dutch respondents were more
concerned about severe and extreme PD and AD than about
problems in the other domains. In the US, MO was the most
important domain. Canada showed the least difference in
impact per domain. Significant differences in coefficients
were noted for PD level 4 (Canada vs. England: P< 0.001)
and level 5 (Canada vs. England, Canada vs. The Nether-
lands, England vs. US, and The Netherlands vs. US:
P < 0.001); AD level 4 (Canada vs. England, England vs. US:
P < 0.001) and level 5 (Canada vs. England, England vs.
US, The Netherlands vs. US: P<0.001); MO level 5 (England
TABLE 1. Characteristics of the 4 Samples
Canada
(N=547)
England
(N=404)
The Netherlands
(N=407)
US
(N=417)
Male (n [%]) 230 (100) 202 (100) 198 (100) 211 (100)
18–24 61 (26.5) 52 (25.7) 35 (17.7) 44 (20.8)
25–34 58 (25.2) 48 (23.8) 22 (11.1) 61 (28.9)
35–44 35 (15.2) 44 (21.8) 45 (22.7) 33 (15.6)
45–54 37 (16.1) 33 (16.3) 48 (24.2) 39 (18.5)
55–64 20 (8.7) 13 (6.4) 34 (17.2) 17 (8.1)
65–74 11 (4.8) 9 (4.5) 12 (6.1) 15 (7.1)
75+ 8 (3.5) 3 (1.3) 2 (1) 2 (1)
Female (n [%]) 317 (100) 202 (100) 209 (100) 206 (100)
18–24 68 (21.4) 52 (25.8) 25 (12.0) 36 (17.5)
25–34 64 (20.2) 63 (31.2) 36 (17.2) 40 (19.4)
35–44 44 (13.9) 32 (15.8) 57 (27.3) 30 (14.6)
45–54 51 (16.1) 31 (15.4) 56 (26.7) 45 (21.8)
55–64 49 (15.5) 12 (5.9) 30 (14.4) 39 (18.9)
65–74 31 (9.8) 9 (4.5) 4 (1.9) 11 (5.3)
75+ 10 (3.2) 3 (1.3) 1 (0.5) 5 (2.4)
Age (mean [SD]) 40.3 (17.3) 36.4 (15.0) 42.2 (14.2) 40.4 (16.0)
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vs. The Netherlands, The Netherlands vs. US (P<0.001), and
Canada vs. US (P=0.001); and UA level 2 (Canada vs. The
Netherlands, England vs. The Netherlands: P<0.001).
Likelihood ratio tests suggested that a pooled model
offered a significantly worse fit to the data than a model with
all parameters estimated separately for each country. In-
clusion of interaction terms for all combinations of the 20
dummies with country (reference: England) revealed that 9
interactions were statistically significant (results not pre-
sented in Table 2). Seven of these involved the domains PD
and AD on levels 4 and 5 for England and The Netherlands.
Separate analyses were performed for the 3 countries
(Canada, England, US) in which the pairs of states from
block 11 were excluded. Comparison with the Dutch sample
showed that omitting those states led to somewhat higher
P-values for the regression coefficients, particularly for
levels 2 and 3. After the analyses without block 11, however,
comparable differences remained between the 3 countries.
Similarity of Health-State Values
The cross-country comparison of predictions for the
complete set of 3125 EQ-5D-5L states demonstrated strong
agreement across the 4 countries (ICC= 0.89) (Fig. 2). Point
estimates for agreement between any 2 countries were strong
(ICC> 0.5), ranging from 0.80 for England versus US to 0.98
for Canada versus US. However, wider confidence intervals
were observed among the countries with lower ICCs. Pear-
son correlation coefficients reflected strength of agreement
among 4 countries compared with the ICC results (Table 3).
Design Efficiency
The predicted values of the health states suggested that the
assumptions underlying the efficient design (plus the manual
changes that were made to it) were reasonable. The pooled
predictions for the 400 states that were part of the 200 paired
comparison tasks showed that many separate health states of the
paired comparison tasks fulfilled efficient design assumptions
(approximately 70% vs. 30% preference). However, many
paired comparison tasks also consisted of health states that were
relatively close to each other in attributed value (Fig. 1).
DISCUSSION
We found that it was feasible to implement a
standardized protocol for computer-based assessment of a
choice-based selection of health states for the EQ-5D-5L
across countries. Models generated parameter estimates that
TABLE 2. Parameter Estimates (Probit Regression) for the 4 Countries Separately and the 4 Countries Together
Canada
N=5470
England
N=4040
The Netherlands
N=4070
US
N=4170
All Countries
N=17,750
Obs=10,940 (54702) Obs=8080 (40402) Obs=8140 (40702) Obs=8340 (41702)
Obs=35,500
(17,7502)
Coefﬁcient SE P Coefﬁcient SE P Coefﬁcient SE P Coefﬁcient SE P Coefﬁcient SE P
Constant 0.203 0.027 0.000 0.085 0.033 0.011 0.161 0.033 0.000 0.028 0.031 0.000 0.124 0.015 0.000
MO2 0.291 0.056 0.000 0.330 0.067 0.000 0.297 0.066 0.000 0.299 0.064 0.000 0.299 0.031 0.000
MO3 0.365 0.063 0.000 0.350 0.078 0.000 0.272 0.075 0.000 0.445 0.073 0.000 0.349 0.035 0.000
MO4 0.930 0.064 0.000 0.930 0.077 0.000 0.984 0.077 0.000 0.925 0.073 0.000 0.923 0.036 0.000
MO5 1.290 0.069 0.000 1.429 0.086 0.000 1.022 0.082 0.000 1.642 0.082 0.000 1.326 0.039 0.000
SC2 0.269 0.059 0.000 0.282 0.072 0.000 0.168 0.071 0.019 0.127 0.069 0.063 0.208 0.033 0.000
SC3 0.339 0.063 0.000 0.319 0.077 0.000 0.255 0.077 0.001 0.251 0.073 0.001 0.290 0.035 0.000
SC4 0.878 0.065 0.000 0.903 0.079 0.000 0.774 0.079 0.000 0.659 0.074 0.000 0.793 0.036 0.000
SC5 0.983 0.062 0.000 1.003 0.076 0.000 0.905 0.074 0.000 1.027 0.072 0.000 0.966 0.035 0.000
UA2 0.258 0.057 0.000 0.363 0.069 0.000 0.044 0.068 0.511 0.196 0.065 0.002 0.194 0.032 0.000
UA3 0.324 0.063 0.000 0.424 0.077 0.000 0.132 0.076 0.079 0.168 0.072 0.020 0.254 0.035 0.000
UA4 0.787 0.062 0.000 0.910 0.076 0.000 0.805 0.075 0.000 0.644 0.071 0.000 0.769 0.035 0.000
UA5 1.062 0.063 0.000 1.069 0.077 0.000 0.951 0.077 0.000 0.938 0.072 0.000 0.987 0.035 0.000
PD2 0.193 0.059 0.001 0.279 0.073 0.000 0.366 0.071 0.000 0.211 0.068 0.002 0.248 0.033 0.000
PD3 0.225 0.063 0.000 0.363 0.077 0.000 0.271 0.076 0.000 0.168 0.072 0.019 0.241 0.035 0.000
PD4 0.847 0.064 0.000 1.276 0.080 0.000 1.150 0.078 0.000 0.957 0.074 0.000 1.017 0.036 0.000
PD5 1.049 0.063 0.000 1.578 0.081 0.000 1.547 0.080 0.000 1.081 0.073 0.000 1.258 0.036 0.000
AD2 0.159 0.060 0.008 0.340 0.074 0.000 0.133 0.075 0.077 0.205 0.070 0.003 0.195 0.034 0.008
AD3 0.433 0.062 0.000 0.564 0.076 0.000 0.397 0.075 0.000 0.475 0.071 0.000 0.454 0.035 0.000
AD4 1.082 0.064 0.000 1.537 0.083 0.000 1.233 0.081 0.000 1.071 0.074 0.000 1.183 0.037 0.000
AD5 1.282 0.065 0.000 1.749 0.084 0.000 1.601 0.084 0.000 1.149 0.076 0.000 1.401 0.038 0.000
Log
likelihood
2861.0236 1890.0615 1995.2784 2165.8822 9043.843
Wald w2 (20) 1407.30 1206.74 1181.84 1085.28 4817.43
AIC 5764.0472 3822.1231 4032.5568 4373.7644 18,129.686
BIC 5917.351 3969.0632 4179.6522 4521.3695 18,307.709
Degrees of
freedom
21 21 21 21 21
Coefficients indicates regression coefficients of the dummies; Constant, represents the alternative-specific constant, capturing a tendency to always choose the first option; Obs,
the number of observations that were used in the analysis; P, P-value (< 0.01 indicates rejection of the null hypothesis).
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logically supported the structure of the descriptive system
and values for EQ-5D-5L health states strongly agreed across
countries, with only minor differences across the 4 countries.
Feedback from respondents indicated that they under-
stood the tasks and interviewers did not report any concerns
about the acceptability of the choice-based tasks. Most
respondents completed the paired comparisons, and few
complained about the difficulty of the information they had
to retain and compare. The number of complete responses
was also high. Nevertheless, the feasibility questions re-
vealed that choosing between the 2 options was not consid-
ered an easy task. In addition, the constant in the model
indicates that a proportion of the respondents were not
performing the tasks carefully. Further research is needed to
better understand the thought processes of respondents.
We expected logical ordering of coefficients in all
countries, but observed a few inconsistencies. These were all
related to illogical ordering from level 2 to level 3 and may
be a result of our modest sample size in each country or other
unidentified reasons. Examining the parameter estimates
across countries revealed high levels of agreement in the
value (overall impact) of the various dimensions. However,
differences between countries were observed, and likelihood
ratio tests supported separate models by country rather than
a single pooled model. Large confidence intervals in agree-
ment based on ICCs between England and the other 3
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FIGURE 2. Relationships between the 3125 estimated (choice model, asmprobit) EQ-5D-5L values (0 =best health state) for the
4 countries compared with the pooled results of the 4 countries (x-axis).
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countries suggest a structural difference between data from
England and the other countries.
After raising the number of levels in the EQ-5D from 3
to 5, the differences between EQ-5D-5L states proved to be
more subtle. Five-level states are much harder to think about
than 3-level states, and a paired comparison of EQ-5D-5L
states that differ only subtly is more difficult than the task
using the previous version (EQ-5D-3L). In addition, the
Bayesian approach to determine the set of paired compar-
isons was programmed in such a way that choice between
states for these pairs would produce a high level of in-
formation but also make it harder to choose.
Choice modeling is a promising avenue for health-state
valuation. There is a revival of interest in these methods due
to the relative simplicity of eliciting ordinal responses and a
widening range of analytic tools to accommodate
them.7,17–21 One previous study suggested that choice mod-
els have a practical advantage: when conducting choice ex-
periments, health states may be evaluated in a self-
completion format using online panels.22 This study con-
firmed that result. In the English arm of this study, data were
obtained through face-to-face interviews. In the other 3
countries, data were collected largely in a self-completion
format. Nonetheless, we observed no appreciable differences
between England and the other countries in data quality (ie,
number of complete responses, duration). This means that
valuation studies based on discrete choices appear to have an
important advantage over TTO techniques because the latter
require face-to-face interviews to produce data of reasonable
credibility.14
One of the most serious limitations of choice-based
models is that they produce relative values. Although dif-
ferences between the values are meaningful, the positions of
the top and bottom values are not interpretable. That is, they
are on an undefined scale (without meaningful anchors such
as 0 = dead and 1 = full health). Several attempts have been
made to resolve this issue.15,17,23,24
A limitation of our study may be that interaction terms
were not included in the modeling, yet they may be found in
the available data. We refrained from this analysis because
the design was generated for main effects only. Other studies
have shown that interactions may be present. This effect
seems moderate; however, and to capture it would require a
more elaborate study.17 Another limitation is the disability to
generalize to older individuals and to those with low edu-
cation, as these were less represented in our study samples.
The paired comparisons offered to respondents in this
study did not specify the duration of the states. It is possible that
the respondents imposed their own ideas about the duration of
the states when making the paired comparisons. Such concealed
ideas about time are probably diverse among the population,
theoretically increasing systematic errors and may be biasing the
obtained health-state values. However, as the 2 states in each of
pairs were similar in the present study, a duration statement may
have minimal impact on the responses. From a measurement
perspective, it may be better to describe the subject of interest
(eg, health states) as uniformly and distinctively as possible.25(p4)
Interest in cross-country variation in health-state val-
uations is growing. There is some evidence that the results
from one country cannot be transferred to other coun-
tries.26–29 These studies suggest that differences exist in the
values given to the same states. However, it is hard to say
whether any differences in these values are due to cultural
notions, methodological differences, or to translational issues
(eg, Dutch wording may make levels 2 and 3 seem closer
together than in other language versions). In this study, the 5
levels in the Dutch and French (Canada) language EQ-5D-5L
may not exactly match the 5 levels in the English language
EQ-5D-5L because of language differences.14 Interestingly,
a recent study to measure disability weights for a wide array
of health outcomes across a diverse range of populations
showed that, based on the same measurement framework that
we used in our study, the differences between countries were
modest.30
To conclude, parameter estimates modeled from a
choice-based approach were generally consistent and logical,
although some deviations were observed. The estimated
values were similar between the countries, and the differ-
ences may be attributed to the administration of the valuation
exercise in different countries, and also due to cultural dif-
ferences. Overall, results indicated that it is feasible to col-
lect valid paired comparison data with limited interviewer
assistance, supporting the possibility of data collection by
means of online panels.
TABLE 3. Correlations, Intraclass Correlations, and Regression
Functions Between the 4 Countries Based on the 3125
Estimated EQ-5D-5L Health States
Relationships Between
Countries
Pearson
Correlation Intraclass Correlation
Correlations
Canada vs. England 0.985 0.839
Canada vs. The
Netherlands
0.971 0.962
Canada vs. US 0.981 0.977
England vs. The
Netherlands
0.978 0.872
England vs. US 0.966 0.802
The Netherlands vs. US 0.937 0.927
Regression functions (R2)
Canada = 0.04+0.80 England (0.97) England = 0.04+1.21
Canada
Canada = 0.36+0.85 The Netherlands
(0.94)
The Netherlands = 0.25+1.11
Canada
Canada = 0.22+0.95 US (0.96) US= 0.13+1.02 Canada
England = 0.42+1.05 The Netherlands
(0.96)
The Netherlands = 0.26+0.91
England
England = 0.31+1.14 US (0.93) US= 0.08+0.82 England
The Netherlands = 0.04+1.03 US (0.88) US= 0.28+0.85 The
Netherlands
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TABLE A1. Final Set of 200 Pairs of EQ-5D-5L Health States for the Choice Experiment
Block Option 1 Option 2 Block Option 1 Option 2 Block Option 1 Option 2 Block Option 1 Option 2
1 35252 32254 6 42122 31325 11 54424 15321 16 23231 25323
44151 53242 43514 23,321 21335 44551 34255 35221
13251 53313 31452 13141 35554 55211 23451 34354
15113 14434 22341 45145 13515 11324 44115 21455
41315 15121 33424 41542 42421 54255 53422 42525
42512 23544 25332 51544 15241 12352 41325 13445
41545 33531 11545 14113 23551 43135 24314 43222
43525 23444 44145 45432 53125 31415 21354 41321
34345 51325 44351 24415 52132 21534 45542 42133
11221* 22122 25212 32443 11122* 23111 11211* 22111
2 52111 11431 7 15555 53455 12 35235 42325 17 43245 34324
45531 14334 43412 13342 42441 21415 55534 33355
51424 35525 33223 21232 25342 51152 33432 15551
15244 44241 23134 14314 14455 15514 13222 31131
11234 21532 51552 35513 51324 34543 42243 35433
11214 45312 54454 24511 52523 54142 15335 43532
34355 43342 14344 52454 12145 15344 12521 41115
54455 55234 22411 43133 52544 34222 51114 41253
44521 41153 51214 45153 35211 42551 31331 35124
13111 11215 11121* 21211 12111* 21121 23233 12411
3 35312 14422 8 13334 45441 13 33111 32545 18 24453 41331
32241 51525 23442 25414 11445 32115 51123 43451
31451 45431 41552 22422 32211 14211 23513 52254
34132 24445 22123 11155 45515 34433 13131 23113
55335 53442 21423 13114 41431 24212 34442 15214
24523 45125 52223 54132 32442 54441 31135 11444
23235 11141 35231 53554 51131 35353 44231 25533
51354 41335 55153 22521 25145 52244 41515 23411
25545 35225 11512 22241 55235 22533 35321 53215
11112* 12221 45115 54225 13553 31234 32334 22254
4 54121 44322 9 51331 22421 14 25235 13413 19 21235 12243
21445 55141 14552 55325 23552 32244 42255 55524
22433 12443 44234 33441 52211 11325 21522 25324
15534 43454 22413 22331 44134 22352 15351 14312
12151 35543 24145 32253 22512 55313 31521 43152
34234 13533 34412 54253 35431 51323 51311 32154
53551 21224 31444 11353 52155 45231 44323 21525
43534 32125 22222 25514 12253 12551 34333 33142
33225 53314 42323 55223 51522 45244 14224 32322
21112* 12211 33243 11115 14333 24424 55244 53531
5 41114 24142 10 33443 54133 15 14122 54231 20 42153 53151
14533 21542 54423 32314 41312 24253 22544 35452
53543 41215 25312 41532 53431 52255 23122 12415
22343 34513 24155 32534 54555 35535 34134 45325
43141 25554 22453 13442 51255 31343 25515 22251
45533 14444 13432 13245 35521 43355 35322 41535
21114 52432 43244 25522 15424 33322 41424 35533
23531 53133 52422 55254 11352 31413 45552 32413
23443 25113 33224 42113 54344 15411 42452 23144
44123 51232 21111* 12121 12112* 22211 11212* 22112
Bold pair is presented in Figure 1.
*The 10 pairs that were manually altered into mild states.
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